Myriad Logo
  • Patients
    • I need help with…
      • Understanding hereditary cancer riskWhat is my risk of developing hereditary cancer?
      • Treating cancerWhat are my treatment options?
      • Prenatal careIs my baby at risk for a genetic condition?
      • Managing mental healthHow might my genes affect my medication outcomes?
    • (sidebar parent)
      • About genetic testing
        • What are the costs of genetic testing?
        • Financial assistance
      • Patient Resources
        • How does genetic testing work?
        • Patient record request
      • Prostate Cancer
        • What are my treatment options?
  • Providers
    • My patient needs a test for…
      • Assessing hereditary cancer riskWhat is my patient’s risk of developing hereditary cancer?
      • Cancer treatmentWhat is the best treatment for my patient?
      • Prenatal careWhat is a pregnancy’s risk of genetic disease?
      • Mental health treatmentHow will my patient metabolize or respond to certain medications?
    • (sidebar parent)
      • About our tests
        • Myriad test catalog
        • Research & whitepapers
        • MyRisk® gene table
        • EMR Integrations
      • Provider resources
        • Order a test
        • Order patient materials
        • Documents & forms
        • Scope of service & lab certificates
        • Provider portal
      • Prostate Cancer Treatment
        • What are my patient’s treatment options?
  • Our Tests
    • Tests for…
      • (column wrapper)
        • Prenatal care
          • Chromosome conditions
          • Genetic diseases
        • Cancer risk assessment
          • Hereditary cancer
        • Mental health
          • Depression
          • Anxiety
          • ADHD
      • (column wrapper)
        • Cancer management
          • Breast cancer
          • Ovarian cancer
          • Pancreatic cancer
          • Prostate cancer
          • Endometrial cancer
          • Other cancers
          • All tests
    • (sidebar parent)
      • TESTS BY SPECIALTY
        • Oncology
        • Urology
        • Imaging
        • OB/GYN
        • Mental Health
        • Internal/Primary care
        • All tests
      • TESTS BY NAME
        • BRACAnalysis CDx®
        • EndoPredict®
        • Foresight®
        • GeneSight®
        • MyChoice® CDx
        • MyRisk® (cancer treatment)
        • MyRisk® (cancer risk)
        • Prequel®
        • Precise™ Tumor
        • Prolaris®
  • About Myriad
    • Who we are
      • Our science & innovation
      • Corporate & social responsibility
    • Latest news
      • Myriad Genetics Blog
    • Corporate information
      • Our leadership
      • Patient advocacy partners
      • Investor relations
      • Careers
    • Partnerships
      • Companion diagnostics
PORTAL ORDER
    Portal
    Order
  • Patients
    • I need help with…
      • Understanding hereditary cancer riskWhat is my risk of developing hereditary cancer?
      • Treating cancerWhat are my treatment options?
      • Prenatal careIs my baby at risk for a genetic condition?
      • Managing mental healthHow might my genes affect my medication outcomes?
    • (sidebar parent)
      • About genetic testing
        • What are the costs of genetic testing?
        • Financial assistance
      • Patient Resources
        • How does genetic testing work?
        • Patient record request
      • Prostate Cancer
        • What are my treatment options?
  • Providers
    • My patient needs a test for…
      • Assessing hereditary cancer riskWhat is my patient’s risk of developing hereditary cancer?
      • Cancer treatmentWhat is the best treatment for my patient?
      • Prenatal careWhat is a pregnancy’s risk of genetic disease?
      • Mental health treatmentHow will my patient metabolize or respond to certain medications?
    • (sidebar parent)
      • About our tests
        • Myriad test catalog
        • Research & whitepapers
        • MyRisk® gene table
        • EMR Integrations
      • Provider resources
        • Order a test
        • Order patient materials
        • Documents & forms
        • Scope of service & lab certificates
        • Provider portal
      • Prostate Cancer Treatment
        • What are my patient’s treatment options?
  • Our Tests
    • Tests for…
      • (column wrapper)
        • Prenatal care
          • Chromosome conditions
          • Genetic diseases
        • Cancer risk assessment
          • Hereditary cancer
        • Mental health
          • Depression
          • Anxiety
          • ADHD
      • (column wrapper)
        • Cancer management
          • Breast cancer
          • Ovarian cancer
          • Pancreatic cancer
          • Prostate cancer
          • Endometrial cancer
          • Other cancers
          • All tests
    • (sidebar parent)
      • TESTS BY SPECIALTY
        • Oncology
        • Urology
        • Imaging
        • OB/GYN
        • Mental Health
        • Internal/Primary care
        • All tests
      • TESTS BY NAME
        • BRACAnalysis CDx®
        • EndoPredict®
        • Foresight®
        • GeneSight®
        • MyChoice® CDx
        • MyRisk® (cancer treatment)
        • MyRisk® (cancer risk)
        • Prequel®
        • Precise™ Tumor
        • Prolaris®
  • About Myriad
    • Who we are
      • Our science & innovation
      • Corporate & social responsibility
    • Latest news
      • Myriad Genetics Blog
    • Corporate information
      • Our leadership
      • Patient advocacy partners
      • Investor relations
      • Careers
    • Partnerships
      • Companion diagnostics

Blog

Blog
  • Category
    • All
    • Patient Blog
    • Patient-Featured
    • Physician Blog
    • Prostate Cancer
    • Provider Blog
    • Providers
    • Urology
    • Video

Empowered by Genetic Testing: How MyRisk® Hereditary Cancer Testing Helps Take Preventive Measures

May 25, 2023

Larry underwent a radical prostatectomy when he was first diagnosed with prostate cancer at age 62. Although the surgery was successful in removing the cancer,...

Continue Reading
A prostate cancer patient and his supportive son

Detecting more prostate cancer earlier with PSMA PET Scans

May 24, 2023

Prostate cancer doesn't always require aggressive treatment. Most men can delay complex treatment until necessary through Active Surveillance according to a ne...

Continue Reading

Understanding Prostate Cancer: A Guide for Men and Their Loved Ones

May 1, 2023

Prostate cancer is a very common disease, roughly 1 in 8 American men will be diagnosed with prostate cancer during their lifetime. Receiving a prostate cancer...

Continue Reading

Healthcare Hero: Kara Cossis, Chesapeake Urology

April 12, 2023

At Myriad Genetics, our mission is to advance health and well-being for all, and a big component of that is developing reliable, accessible genetic tests for a...

Continue Reading

Medical Experts Discuss Benefits of Genetic Testing in Prostate Cancer Care

March 23, 2023

In a recent Myriad Live webinar, our Chief Medical Officer, Thomas Slavin, hosted a lively conversation about prostate cancer with two experts from the field: ...

Continue Reading

Prostate Cancer Proactive Healthcare Steps

March 17, 2023

Author: Geoff McLennan, prostate cancer patient and advocate Every January since 1951 the American Cancer Society (ACS) has published an annual report about...

Continue Reading

Expanding access to PARP inhibitors in prostate cancer treatment

March 14, 2023

Last month, Myriad attended the 2023 ASCO Genitourinary Cancers Symposium (ASCO GU) to connect with researchers and doctors around emergent and controversial a...

Continue Reading

Personalized Prostate Cancer Treatment: The Role of the Prolaris® Test

March 10, 2023

Prostate cancer is a common cancer affecting men, and historically the most common approach to treatment would be either surgery or radiation therapy. However,...

Continue Reading

American Cancer Society® Reports Increase in Late-Stage Prostate Cancer

February 3, 2023

Amid the great news reported recently by the American Cancer Society — that overall deaths from cancer have dropped by a third since 1991, saving nearly 4 mi...

Continue Reading

How is the Prostate Gleason Score Graded? Your Biopsy and Gleason Score Part 2

February 1, 2023

Geoff McLennan, Prostate Cancer Survivor and Advocate In part one of this blog series, I explained the different types of prostate biopsies available ...

Continue Reading

Types of Prostate Biopsies: Your biopsy and Gleason score Part 1

January 23, 2023

Geoff McLennan, Prostate Cancer Survivor and Advocate A urologist will usually, but not always, suggest a biopsy of your prostate when there is reason ...

Continue Reading

Prostate cancer can be hereditary, get peace of mind with Myriad Genetic Testing

January 13, 2023

https://myriad-1.wistia.com/medias/yff9ux0rmk When Tim Petracca was diagnosed with prostate cancer at age 63, he began to think about his extensive fa...

Continue Reading

Patient PSA Test Primer: Best times to test and how to prepare

January 6, 2023

Geoff McLennan, Prostate Cancer Survivor and Advocate As men enter, or race, into middle-age, and their doctors add another level of care, the first of ma...

Continue Reading

Prolaris® provides clarity for prostate cancer treatment decisions. A patient story.

December 12, 2022

https://myriad-1.wistia.com/medias/70m1vw0uka Elevated PSA levels warning Tim Petracca was a healthy 63-year-old when he attended a regularly sched...

Continue Reading

Patient Prostate Cancer Journey Part 3: Shared Decision-Making Benefits to Prostate Cancer Treatment

December 1, 2022

A transparent, confident relationship with your urologist is important not only for your current health, but for your future health outcomes. The good new...

Continue Reading
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • Managed care
    • Payers
  • Investors
    • Investor relations
  • News
    • Press releases
    • Myriad Genetics’ Blog
  • About
    • Careers
    • Contact us
  • Terms of Use
  • Myriad Genetics, Inc. Privacy Notice
  • HIPAA Notice of Privacy Practices
  • Patents
  • Language Assistance
  • Cookie Preferences
facebook linkedin twitter instagram youtube

Health. Illuminated.

  • © 2023 Myriad Genetics, Inc.

Locations

United States
Europe
Japan